Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Eukaryotic Gene Expression
IF: 1.841 5-Year IF: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Print: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2018021528
pages 73-86

Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications

Nida Noreen
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Pakistan
Faqir Muhammad
Institute of Pharmacy, Physiology and Pharmacology, Faculty of Veterinary Science, University of Agriculture, Faisalabad, Pakistan
Bushra Akhtar
Institute of Pharmacy, Physiology and Pharmacology, Faculty of Veterinary Science, University of Agriculture, Faisalabad, Pakistan
Farooq Azam
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Pakistan
Muhammad Irfan Anwar
Faculty of Veterinary Science, Bahauddin Zakariya University, Multan, Pakistan

ABSTRACT

The pharmacological importance of cannabidiol (CBD) has been in study for several years. CBD is the major nonpsychoactive constituent of plant Cannabis sativa and its administration is associated with reduced side effects. Currently, CBD is undergoing a lot of research which suggests that it has no addictive effects, good safety profile and has exhibited powerful therapeutic potential in several vital areas. It has wide spectrum of action because it acts through endocannabinoid receptors; CB1 and CB2 and it also acts on other receptors, such as GPR18, GPR55, GPR 119, 5HT1A, and TRPV2. This indicates its therapeutic value for numerous medical conditions because of its neuroprotective and immunomodulatory properties. Potential therapeutic applications of CBD include, analgesic, anti-inflammatory, anxiolytic, anti-arthritic, anti-depressant, anti-Alzheimer disease, anti-ischemic, neuroprotective, and anti-fibrotic. More promising areas appear to include diabetes and cancer where CBD exhibits lesser side effects and more therapeutic benefits as compared to recent available medical therapies. Hence, CBD is a promising substance for the development of new drug. However further research and clinical studies are required to explore its complete potential.


Articles with similar content:

Use of ALA and ALA Derivatives for Optimizing ALA-based Photodynamic Therapy: A Review of Our Experience
Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 1-2
Haydee Fukuda, Alcira Batlle, Adriana Casas
Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 1-2
Mark B. Faries
Modulators of Androgen and Estrogen Receptor Activity
Critical Reviews™ in Eukaryotic Gene Expression, Vol.20, 2010, issue 4
Bart L. Clarke, Sundeep Khosla
Venoms Can Be a Boon for Cancer Patients
Forum on Immunopathological Diseases and Therapeutics, Vol.4, 2013, issue 3-4
Sudhir Kumar, Ruchi Jain, Puja Sarkar
Review of Advances in Bioactive Low-Molecular-Weight Compounds, Extracts, and Biology of Phellinus sensu lato Mushrooms (Agaricomycetes) from 2011 to 2017
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 9
Ling Sun, Xiaofei Ye, Golly K. Moses, Cunshan Zhou, Henan Zhang, Mohammed A.Y. Abdualrahman, Yating Dong, Haile Ma